Overview
Mark Huberman is an Oncologist in Newton, Massachusetts. Dr. Huberman is rated as a Distinguished provider by MediFind in the treatment of ALK-Positive Non-Small Cell Lung Cancer. His top areas of expertise are EGFR Positive Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, and Lung Adenocarcinoma.
His clinical research consists of co-authoring 29 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Dana-Farber Cancer Institute, Lowe Center For Thoracic Oncology
Michael Rabin is an Oncologist in Boston, Massachusetts. Dr. Rabin is rated as a Distinguished provider by MediFind in the treatment of ALK-Positive Non-Small Cell Lung Cancer. His top areas of expertise are EGFR Positive Lung Cancer, Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), and Lung Adenocarcinoma.
Massachusetts General Physicians Organization Inc
Jennifer Temel is an Oncologist in Boston, Massachusetts. Dr. Temel is rated as an Elite provider by MediFind in the treatment of ALK-Positive Non-Small Cell Lung Cancer. Her top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), EGFR Positive Lung Cancer, Bone Marrow Transplant, and Gastrostomy.
Dana-Farber Cancer Institute, Inc.
David Jackman is an Oncologist in Chestnut Hill, Massachusetts. Dr. Jackman is rated as an Elite provider by MediFind in the treatment of ALK-Positive Non-Small Cell Lung Cancer. His top areas of expertise are EGFR Positive Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, and Mesothelioma. Dr. Jackman is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- ALK-Positive Non-Small Cell Lung CancerDr. Huberman isDistinguished. Learn about ALK-Positive Non-Small Cell Lung Cancer.
- EGFR Positive Lung CancerDr. Huberman isDistinguished. Learn about EGFR Positive Lung Cancer.
- Lung AdenocarcinomaDr. Huberman isDistinguished. Learn about Lung Adenocarcinoma.
- Lung CancerDr. Huberman isDistinguished. Learn about Lung Cancer.
- Non-Small Cell Lung Cancer (NSCLC)Dr. Huberman isDistinguished. Learn about Non-Small Cell Lung Cancer (NSCLC).
- Pleuropulmonary BlastomaDr. Huberman isDistinguished. Learn about Pleuropulmonary Blastoma.
- Advanced
- Large-Cell Lung CarcinomaDr. Huberman isAdvanced. Learn about Large-Cell Lung Carcinoma.
- Experienced
- B-Cell LymphomaDr. Huberman isExperienced. Learn about B-Cell Lymphoma.
- Breast CancerDr. Huberman isExperienced. Learn about Breast Cancer.
- Colorectal CancerDr. Huberman isExperienced. Learn about Colorectal Cancer.
- Familial Colorectal CancerDr. Huberman isExperienced. Learn about Familial Colorectal Cancer.
- Follicular LymphomaDr. Huberman isExperienced. Learn about Follicular Lymphoma.
- Inflammatory Breast CancerDr. Huberman isExperienced. Learn about Inflammatory Breast Cancer.